Frontiers in Cellular and Infection Microbiology

Article	Citations
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development	535
Antibiotics as Major Disruptors of Gut Microbiota	364
ACE2, Much More Than Just a Receptor for SARS-COV-2	265
Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)	243
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields	216
The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)	215
Role and Mechanism of Gut Microbiota in Human Disease	203
Antibiotic Resistance: One Health One World Outlook	199
Fungi vs. Fungi in Biocontrol: An Overview of Fungal Antagonists Applied Against Fungal Plant Pathogens	186
Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China	181
Modern Tools for Rapid Diagnostics of Antimicrobial Resistance	162
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species	154
SARS-COV-2 Variants: Differences and Potential of Immune Evasion	143
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey	139
The Female Vaginal Microbiome in Health and Bacterial Vaginosis	124
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System	119
Periodontal Disease: The Good, The Bad, and The Unknown	113
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria	112
The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis: Implications for Neurological Disorders	111
Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential	111
Wuhan to World: The COVID-19 Pandemic	109
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression	107
The Gut Microbiota in Inflammatory Bowel Disease	106
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine	105
Urinary Microbiome: Yin and Yang of the Urinary Tract	105

Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome	100
Gut Microbiota Dysbiosis Associated With Altered Production of Short Chain Fatty Acids in Children With Neurodevelopmental Disorders	99
Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan	98
Development and Validation of a Rapid, Single-Step Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) System Potentially to Be Used for Reliable and High-Throughput Screening of CO	98
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics	98
Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs	95
Promising Therapeutic Strategies Against Microbial Biofilm Challenges	94
Extracellular Vesicles in Fungi: Past, Present, and Future Perspectives	94
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies	92
Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities	91
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro	90
Chitosan-Based Nanoparticles Against Viral Infections	87
The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases	86
An Update on Molecular Diagnostics for COVID-19	86
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease	86
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia	84
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy	83
Gut Microbiota and Diarrhea: An Updated Review	82
Gut Microbiota Status in COVID-19: An Unrecognized Player?	82
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection	82
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus	81
A Novel Scoring System for Prediction of Disease Severity in COVID-19	80
Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis	80
Proteus mirabilis Biofilm: Development and Therapeutic Strategies	78
Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection	78
Recent Advances in Molecular Diagnostics of Fungal Plant Pathogens: A Mini Review	78
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy	77
Quorum Sensing, Biofilm, and Intestinal Mucosal Barrier: Involvement the Role of Probiotic	75
An Overview of Anti-Eukaryotic T6SS Effectors	74
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation	74
Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium	74
Diversity of Hybrid- and Hetero-Pathogenic Escherichia coli and Their Potential Implication in More Severe Diseases	74
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy	73
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance	73
A Human 2D Primary Organoid-Derived Epithelial Monolayer Model to Study Host-Pathogen Interaction in the Small Intestine	71
Bacterial Community Interactions During Chronic Respiratory Disease	71
Viral Infections, the Microbiome, and Probiotics	71
Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples	69
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome	69
Structural Variations of Vaginal and Endometrial Microbiota: Hints on Female Infertility	68
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial	68
How to Count Our Microbes? The Effect of Different Quantitative Microbiome Profiling Approaches	67
The Microbiota of the Human Mammary Ecosystem	66
Herpes Simplex Virus Cell Entry Mechanisms: An Update	66
Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis	66
Hypoxia Inducible Factor-1α: The Curator of Gut Homeostasis	66
The Impact of Gut Microbiota on Radiation-Induced Enteritis	65
Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection	65
Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review	65
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota	64

Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area	62
C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens	62
Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen	61
RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact	61
The Gut Microbiota of Critically Ill Patients With COVID-19	61
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing	60
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions	60
Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants	60
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis	59
Bacterial Vaginosis: What Do We Currently Know?	59
Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities	59
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota	58
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study	58
Cutaneous Malassezia: Commensal, Pathogen, or Protector?	58
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?	58
Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients	57
Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future	57
CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care Diagnostics	57
IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection	57
Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis	57
A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy	56
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease	56
Review on the Current Trends of Toxoplasmosis Serodiagnosis in Humans	55
Antimicrobial Activity of Lemongrass Essential Oil (Cymbopogon flexuosus) and Its Active Component Citral Against Dual-Species Biofilms of Staphylococcus aureus and Candida Species	55
Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases	55
Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli	54
Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics	54
Bipolaris sorokiniana-Induced Black Point, Common Root Rot, and Spot Blotch Diseases of Wheat: A Review	54
The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People	53
Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis	53
A Saliva-Based RNA Extraction-Free Workflow Integrated With Cas13a for SARS-CoV-2 Detection	53
Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation	53
Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer	52
Improving Pulmonary Infection Diagnosis with Metagenomic Next Generation Sequencing	52
Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation	52
Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection	52
Recent advances in recombinase polymerase amplification: Principle, advantages, disadvantages and applications	52
Antibiotic Resistance and Virulence Profiles of Klebsiella pneumoniae Strains Isolated From Different Clinical Sources	51
Sugar-Coated Killer: Serotype 3 Pneumococcal Disease	51
Azole Use in Agriculture, Horticulture, and Wood Preservation – Is It Indispensable?	51
The Anti-colitis Effect of Schisandra chinensis Polysaccharide Is Associated With the Regulation of the Composition and Metabolism of Gut Microbiota	51
Determinants of Vaginal Microbiota Composition	51
Influence of the Host and Parasite Strain on the Immune Response During Toxoplasma Infection	51
Oxidative Stress and Pathogenesis in Malaria	51
Francisella tularensis, Tularemia and Serological Diagnosis	51
Malassezia spp. Yeasts of Emerging Concern in Fungemia	51
Role of Cytokines in Experimental and Human Visceral Leishmaniasis	50
Shining Light on Human Gut Bacteriophages	50
Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study	50
One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar	50
Combination Therapies for Biofilm Inhibition and Eradication: A Comparative Review of Laboratory and Preclinical Studies	50
Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems	49
Fussing About Fission: Defining Variety Among Mainstream and Exotic Apicomplexan Cell Division Modes	49
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19	49
Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach	48
Planctomycetes as Host-Associated Bacteria: A Perspective That Holds Promise for Their Future Isolations, by Mimicking Their Native Environmental Niches in Clinical Microbiology Laboratories	48
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients	48
Pulsatilla chinensis Saponins Ameliorate Inflammation and DSS-Induced Ulcerative Colitis in Rats by Regulating the Composition and Diversity of Intestinal Flora	48
The Oral Microbiome in Periodontal Health	48
Prevalence and Clonal Distribution of Azole-Resistant Candida parapsilosis Isolates Causing Bloodstream Infections in a Large Italian Hospital	48
Amylases: Biofilm Inducer or Biofilm Inhibitor?	47
The Human Skin Microbiome in Selected Cutaneous Diseases	47
Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections	47
Intracellular Porphyromonas gingivalis Promotes the Proliferation of Colorectal Cancer Cells via the MAPK/ERK Signaling Pathway	47
Extracellular Vesicles in Viral Infections: Two Sides of the Same Coin?	47
Regulations of Glycolytic Activities on Macrophages Functions in Tumor and Infectious Inflammation	46
Epidemiological Investigation and Antimicrobial Resistance Profiles of Salmonella Isolated From Breeder Chicken Hatcheries in Henan, China	46
Alterations of the Gut Microbiome Composition and Lipid Metabolic Profile in Radiation Enteritis	46
Neuroinflammation, Sleep, and Circadian Rhythms	46
Extracellular Vesicles in Trypanosomatids: Host Cell Communication	46
The Diagnostic Value of Metagenomic Next–Generation Sequencing in Lower Respiratory Tract Infection	45
The Dynamic Roles of the Inner Membrane Complex in the Multiple Stages of the Malaria Parasite	45
Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome	45
The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis	45
Alterations of Gastric Microbiota in Gastric Cancer and Precancerous Stages	44
Association Between Oral Microbiota and Cigarette Smoking in the Chinese Population	43
Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach	43
The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis	43
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota	43
The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome	43

The Role of Tricarboxylic Acid Cycle Metabolites in Viral Infections	43
Impact of Age and Sex on COVID-19 Severity Assessed From Radiologic and Clinical Findings	43
Block and Lock HIV Cure Strategies to Control the Latent Reservoir	43
Salmonella Biofilm Formation, Chronic Infection, and Immunity Within the Intestine and Hepatobiliary Tract	43
Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Bl	43
Microbial Colonization From the Fetus to Early Childhood—A Comprehensive Review	42
Review: The Emerging Role of Neutrophil Extracellular Traps in Sepsis and Sepsis-Associated Thrombosis	42
Role of Platelet Cytokines in Dengue Virus Infection	42
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy	42
Synergism of Streptococcus mutans and Candida albicans Reinforces Biofilm Maturation and Acidogenicity in Saliva: An In Vitro Study	42
Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic	42
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)	42
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life	41
Altered Fecal Microbiota Composition in Older Adults With Frailty	41
Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2	41
The Microbiome Composition of a Man's Penis Predicts Incident Bacterial Vaginosis in His Female Sex Partner With High Accuracy	41
Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model	41
Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections	41
Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals	40
Intestinal Microbiota Mediates High-Fructose and High-Fat Diets to Induce Chronic Intestinal Inflammation	40
Overview of the Potential Role of Malassezia in Gut Health and Disease	40
Antimicrobial Peptides Human Beta-Defensin-2 and -3 Protect the Gut During Candida albicans Infections Enhancing the Intestinal Barrier Integrity: In Vitro Study	40
Gut Microbiota: Its Potential Roles in Pancreatic Cancer	40
Virulence Regulation and Innate Host Response in the Pathogenicity of Vibrio cholerae	40
The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy	40
Foundation and Clinical Evaluation of a New Method for Detecting SARS-CoV-2 Antigen by Fluorescent Microsphere Immunochromatography	40
Vaginal Microbiome Composition in Early Pregnancy and Risk of Spontaneous Preterm and Early Term Birth Among African American Women	40
Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies	40
Role of Cell Surface Hydrophobicity in the Pathogenesis of Medically-Significant Fungi	39
The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment	39
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review	39
Fecal and Serum Metabolomic Signatures and Microbial Community Profiling of Postmenopausal Osteoporosis Mice Model	39
Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae	39
The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy	39
Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells	39
Analytical and Clinical Evaluation of “AccuPower SARS-CoV-2 Multiplex RT-PCR kit (Bioneer, South Korea)” and “Allplex 2019-nCoV Assay (Seegene, South Korea)” for SARS-CoV-2 RT-PCR Diagnosis: Korean CD	39
TickSialoFam (TSFam): A Database That Helps to Classify Tick Salivary Proteins, a Review on Tick Salivary Protein Function and Evolution, With Considerations on the Tick Sialome Switching Phenomenon	39
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets	38
Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions	38
The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies	38
Alteration of Gut Microbiome and Correlated Lipid Metabolism in Post-Stroke Depression	38
Peptidylarginine Deiminase Inhibition Abolishes the Production of Large Extracellular Vesicles From Giardia intestinalis, Affecting Host-Pathogen Interactions by Hindering Adhesion to Host Cells	38
Roles of Gut Microbiota in the Regulation of Hippocampal Plasticity, Inflammation, and Hippocampus-Dependent Behaviors	38
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications	38
Host Innate Immune Responses to Acinetobacter baumannii Infection	38
Laboratory Diagnostic Tools for Syphilis: Current Status and Future Prospects	38
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants	38
High-Fat Diet Induced Alteration of Mice Microbiota and the Functional Ability to Utilize Fructooligosaccharide for Ethanol Production	38
Analysis of Resistance to Florfenicol and the Related Mechanism of Dissemination in Different Animal-Derived Bacteria	38
Lactobacillus rhamnosus Strains Relieve Loperamide-Induced Constipation via Different Pathways Independent of Short-Chain Fatty Acids	37
Tick Saliva and the Alpha-Gal Syndrome: Finding a Needle in a Haystack	37
CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics	37
Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study	37
Factors Associated With MALDI-TOF Mass Spectral Quality of Species Identification in Clinical Routine Diagnostics	37
Recent Advances in Research on Antibacterial Metals and Alloys as Implant Materials	37
Bacteriophage Cocktails Protect Dairy Cows Against Mastitis Caused By Drug Resistant Escherichia coli Infection	37
Revisiting Campylobacter jejuni Virulence and Fitness Factors: Role in Sensing, Adapting, and Competing	37
Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus	37
Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response	37
Gut Microbiota Exceeds Cervical Microbiota for Early Diagnosis of Endometriosis	37
Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge	37
Host-Malaria Parasite Interactions and Impacts on Mutual Evolution	37
ACE2 Shedding and the Role in COVID-19	37
Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury	37
Short-Chain Fatty Acid and FFAR2 Activation – A New Option for Treating Infections?	37
Fecal Microbiota Changes in Patients With Postpartum Depressive Disorder	36
Unraveling Pseudomonas aeruginosa and Candida albicans Communication in Coinfection Scenarios: Insights Through Network Analysis	36
Low-Abundant Microorganisms: The Human Microbiome’s Dark Matter, a Scoping Review	36
Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling	36
Poor Unstable Midgut Microbiome of Hard Ticks Contrasts With Abundant and Stable Monospecific Microbiome in Ovaries	36
Effects of Berberine on the Gastrointestinal Microbiota	36
Drosophila as a Model Organism in Host–Pathogen Interaction Studies	36
Survival and Control of Campylobacter in Poultry Production Environment	36
COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia	35
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives	35
A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes	35
Aedes Mosquito Salivary Components and Their Effect on the Immune Response to Arboviruses	35
Acaricides Resistance in Ticks: Selection, Diagnosis, Mechanisms, and Mitigation	35
Diagnostic Methods, Clinical Guidelines, and Antibiotic Treatment for Group A Streptococcal Pharyngitis: A Narrative Review	35
The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study	35
Cathepsins in Bacteria-Macrophage Interaction: Defenders or Victims of Circumstance?	35
Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension	35
Forensic Analysis of Human Microbiome in Skin and Body Fluids Based on Geographic Location	34
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy	34
Next-Generation Sequencing Reveals the Progression of COVID-19	34
The Fungal Microbiome and Asthma	34
Emerging Evasion Mechanisms of Macrophage Defenses by Pathogenic Bacteria	34
Vaginal Microbiota and Cytokine Levels Predict Preterm Delivery in Asian Women	34
Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography	34
A Study on the Prevalence and Subtype Diversity of the Intestinal Protist Blastocystis sp. in a Gut-Healthy Human Population in the Czech Republic	34
COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding	34
Extracellular Histone H3 Induces Pyroptosis During Sepsis and May Act Through NOD2 and VSIG4/NLRP3 Pathways	34
Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis	34
No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection	34
Interfering with Autophagy: The Opposing Strategies Deployed by Legionella pneumophila and Coxiella burnetii Effector Proteins	34